KRAS and adenocarcinoma: Genetic sequence and pathological analysis revealed that these two tumor samples lacked mutations in the KRAS gene and exhibited pathological features of adenocarcinoma, similar to the TPMCa and TPMR1 mouse tumor models (Figure S6E–G, Supporting Information).